GREAT POINT PARTNERS LLC - RELMADA THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 118 filers reported holding RELMADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
GREAT POINT PARTNERS LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$18,880,000
+42.0%
510,000
-27.1%
4.55%
+42.6%
Q2 2022$13,293,000
-37.7%
700,000
-11.4%
3.19%
-38.1%
Q1 2022$21,322,000
+31.9%
790,000
+10.1%
5.15%
+43.5%
Q4 2021$16,161,000–717,320–3.59%–
 Download
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Deep Track Capital, LP 2,837,818$9,903,9850.42%
Sio Capital Management, LLC 235,500$821,8950.30%
Sio Capital Management, LLC 235,600$822,2440.30%
apricus wealth, LLC 77,329$269,8780.25%
RTW INVESTMENTS, LP 2,067,824$7,216,7060.15%
PARSONS CAPITAL MANAGEMENT INC/RI 496,254$1,731,9260.14%
Aristides Capital LLC 69,322$241,9340.12%
XTX Topco Ltd 129,387$451,5610.10%
AdvisorShares Investments LLC 81,362$283,9530.08%
Ikarian Capital, LLC 65,491$228,5630.06%
View complete list of RELMADA THERAPEUTICS INC shareholders